News | March 20, 2025
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
FlexiTubes will showcase range of eco-friendly and innovative tube options
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
